Nature, ISSN 0028-0836, 06/2010, Volume 465, Issue 7299, pp. 808 - 812
The generation of reprogrammed induced pluripotent stem cells (iPSCs) from patients with defined genetic disorders holds the promise of increased understanding...
SOMATIC PTPN11 MUTATIONS | SHP2 MUTATIONS | HUMAN ES | HEMATOPOIESIS | MULTIDISCIPLINARY SCIENCES | CARDIAC-HYPERTROPHY | DISEASE | LEUKEMOGENESIS | DIFFERENTIATION | LEUKEMIA | FIBROBLASTS | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | Embryonic Stem Cells - metabolism | Humans | Male | Gene Expression Profiling | LEOPARD Syndrome - drug therapy | Octamer Transcription Factor-3 - genetics | Phosphoproteins - analysis | SOXB1 Transcription Factors - genetics | Polymerase Chain Reaction | Adult | Female | Cell Differentiation | Fibroblasts - metabolism | Induced Pluripotent Stem Cells - metabolism | Precision Medicine | Induced Pluripotent Stem Cells - pathology | Cell Line | Induced Pluripotent Stem Cells - enzymology | Nanog Homeobox Protein | LEOPARD Syndrome - metabolism | NFATC Transcription Factors - metabolism | Cells, Cultured | Fibroblasts - pathology | Homeodomain Proteins - genetics | Cell Lineage | Myocytes, Cardiac - pathology | Models, Biological | LEOPARD Syndrome - pathology | Myocytes, Cardiac - metabolism | Enzyme Activation | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Mitogen-Activated Protein Kinases - metabolism | NFATC Transcription Factors - genetics | Proteins | Signal transduction | Insects | Genes | Cardiomyocytes | Mutation | Kinases
SOMATIC PTPN11 MUTATIONS | SHP2 MUTATIONS | HUMAN ES | HEMATOPOIESIS | MULTIDISCIPLINARY SCIENCES | CARDIAC-HYPERTROPHY | DISEASE | LEUKEMOGENESIS | DIFFERENTIATION | LEUKEMIA | FIBROBLASTS | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - metabolism | Embryonic Stem Cells - metabolism | Humans | Male | Gene Expression Profiling | LEOPARD Syndrome - drug therapy | Octamer Transcription Factor-3 - genetics | Phosphoproteins - analysis | SOXB1 Transcription Factors - genetics | Polymerase Chain Reaction | Adult | Female | Cell Differentiation | Fibroblasts - metabolism | Induced Pluripotent Stem Cells - metabolism | Precision Medicine | Induced Pluripotent Stem Cells - pathology | Cell Line | Induced Pluripotent Stem Cells - enzymology | Nanog Homeobox Protein | LEOPARD Syndrome - metabolism | NFATC Transcription Factors - metabolism | Cells, Cultured | Fibroblasts - pathology | Homeodomain Proteins - genetics | Cell Lineage | Myocytes, Cardiac - pathology | Models, Biological | LEOPARD Syndrome - pathology | Myocytes, Cardiac - metabolism | Enzyme Activation | Protein Tyrosine Phosphatase, Non-Receptor Type 11 - genetics | Mitogen-Activated Protein Kinases - metabolism | NFATC Transcription Factors - genetics | Proteins | Signal transduction | Insects | Genes | Cardiomyocytes | Mutation | Kinases
Journal Article
Stem Cell Research, ISSN 1873-5061, 05/2016, Volume 16, Issue 3, pp. 617 - 621
Mef2c Anterior Heart Field (AHF) enhancer is activated during embryonic heart development and it is expressed in multipotent cardiovascular progenitors (CVP)...
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | MEF2 Transcription Factors - genetics | Mice, Inbred C57BL | Genotype | Mice, Transgenic | Transcription Factors - genetics | Cellular Reprogramming | Myocardium - cytology | Teratoma - metabolism | Embryoid Bodies - metabolism | Transcription Factors - metabolism | Teratoma - pathology | Animals | Embryoid Bodies - cytology | Cell Differentiation | Fibroblasts - cytology | Mice | Induced Pluripotent Stem Cells - cytology | Karyotype | Induced Pluripotent Stem Cells - metabolism
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | MEF2 Transcription Factors - genetics | Mice, Inbred C57BL | Genotype | Mice, Transgenic | Transcription Factors - genetics | Cellular Reprogramming | Myocardium - cytology | Teratoma - metabolism | Embryoid Bodies - metabolism | Transcription Factors - metabolism | Teratoma - pathology | Animals | Embryoid Bodies - cytology | Cell Differentiation | Fibroblasts - cytology | Mice | Induced Pluripotent Stem Cells - cytology | Karyotype | Induced Pluripotent Stem Cells - metabolism
Journal Article
Stem Cell Research, ISSN 1873-5061, 04/2019, Volume 36, p. 101410
We have generated two human induced pluripotent stem cell (iPSC) lines from CD133 cells isolated from umbilical cord blood (CB) of a female child using...
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY
Journal Article
Stem Cell Research, ISSN 1873-5061, 04/2019, Volume 36
We have generated two human induced pluripotent stem cell (iPSC) lines from CD133.sup.+ cells isolated from umbilical cord blood (CB) of a female child using...
Blood cells | Analysis | Stem cells | Cell lines | Research | Umbilical cord
Blood cells | Analysis | Stem cells | Cell lines | Research | Umbilical cord
Journal Article
Stem Cell Research, ISSN 1873-5061, 12/2018, Volume 33, pp. 125 - 129
Islet-1 (Isl1) is a transcription factor essential for life expressed in specific cells with different developmental origins. We have generated iPSC lines from...
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Fibroblasts | Transcription factors | Research | Stem cells
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Fibroblasts | Transcription factors | Research | Stem cells
Journal Article
Cardiovascular Research, ISSN 0008-6363, 2012, Volume 95, Issue 3, pp. 327 - 335
A variety of human inherited heart diseases affect the normal functions of cardiomyocytes (CMs), endothelial cells (ECs), or smooth muscle cells (SMCs). To...
Differentiation | Embryonic stem cells | Induced pluripotent stem cells | Cardiovascular cells | PROGENITOR CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | MOUSE | ALCAM CD166 | SURFACE-MARKER | CARDIOMYOCYTES | PLURIPOTENT STEM-CELLS | HEART | ENDOTHELIAL-CELLS | SELECTION | CARDIAC MORPHOGENESIS | LEOPARD Syndrome - physiopathology | Humans | Multipotent Stem Cells - metabolism | LEOPARD Syndrome - genetics | Cardiomegaly - pathology | Fetal Proteins - metabolism | RNA, Messenger - metabolism | Antigens, CD - metabolism | Flow Cytometry | Time Factors | Cell Adhesion Molecules, Neuronal - metabolism | Cell Differentiation | Multipotent Stem Cells - physiology | Myocytes, Smooth Muscle - metabolism | Induced Pluripotent Stem Cells - metabolism | Biomarkers - metabolism | Reproducibility of Results | Induced Pluripotent Stem Cells - physiology | Cells, Cultured | Gene Expression Regulation | Myocytes, Smooth Muscle - physiology | Cardiomegaly - physiopathology | Genotype | Cell Separation - methods | Mice, SCID | Cell Lineage | Phenotype | Animals | Myocytes, Cardiac - physiology | LEOPARD Syndrome - pathology | Myocytes, Cardiac - metabolism | Mice, Inbred NOD | Mice | Cardiomegaly - genetics | Original
Differentiation | Embryonic stem cells | Induced pluripotent stem cells | Cardiovascular cells | PROGENITOR CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | MOUSE | ALCAM CD166 | SURFACE-MARKER | CARDIOMYOCYTES | PLURIPOTENT STEM-CELLS | HEART | ENDOTHELIAL-CELLS | SELECTION | CARDIAC MORPHOGENESIS | LEOPARD Syndrome - physiopathology | Humans | Multipotent Stem Cells - metabolism | LEOPARD Syndrome - genetics | Cardiomegaly - pathology | Fetal Proteins - metabolism | RNA, Messenger - metabolism | Antigens, CD - metabolism | Flow Cytometry | Time Factors | Cell Adhesion Molecules, Neuronal - metabolism | Cell Differentiation | Multipotent Stem Cells - physiology | Myocytes, Smooth Muscle - metabolism | Induced Pluripotent Stem Cells - metabolism | Biomarkers - metabolism | Reproducibility of Results | Induced Pluripotent Stem Cells - physiology | Cells, Cultured | Gene Expression Regulation | Myocytes, Smooth Muscle - physiology | Cardiomegaly - physiopathology | Genotype | Cell Separation - methods | Mice, SCID | Cell Lineage | Phenotype | Animals | Myocytes, Cardiac - physiology | LEOPARD Syndrome - pathology | Myocytes, Cardiac - metabolism | Mice, Inbred NOD | Mice | Cardiomegaly - genetics | Original
Journal Article
Stem Cell Research, ISSN 1873-5061, 05/2017, Volume 21, Issue C, pp. 1 - 4
We generated ATCi-MF1 induced pluripotent stem (iPS) cell line from adult skin fibroblasts using non-integrative Sendai viruses carrying OCT3/4, KLF4, SOX2 and...
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cell Line | Skin - cytology | Transduction, Genetic | Sendai virus | Skin - metabolism | Macaca fascicularis | Transcription Factors - biosynthesis | Transcription Factors - genetics | Animals | Fibroblasts - cytology | Induced Pluripotent Stem Cells - cytology | Fibroblasts - metabolism | Induced Pluripotent Stem Cells - metabolism | Usage | Parainfluenza viruses | Stem cells | Physiological aspects | Fibroblasts | Kra | Research
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cell Line | Skin - cytology | Transduction, Genetic | Sendai virus | Skin - metabolism | Macaca fascicularis | Transcription Factors - biosynthesis | Transcription Factors - genetics | Animals | Fibroblasts - cytology | Induced Pluripotent Stem Cells - cytology | Fibroblasts - metabolism | Induced Pluripotent Stem Cells - metabolism | Usage | Parainfluenza viruses | Stem cells | Physiological aspects | Fibroblasts | Kra | Research
Journal Article
Cancer Research, ISSN 0008-5472, 06/2006, Volume 66, Issue 11, pp. 5781 - 5789
Multiple myeloma represents an incurable disease, for which development of new therapies is required. Here, we report the effect on myeloma cells of LBH589, a...
MOLECULAR SEQUELAE | PROTEIN | PROMYELOCYTIC LEUKEMIA | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | INDUCED APOPTOSIS | DOWN-REGULATION | SURFACE | DEATH | MECHANISMS | MULTIPLE-MYELOMA CELLS | Apoptosis - drug effects | Humans | Pyrazines - administration & dosage | Drug Resistance, Neoplasm | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Hydroxamic Acids - administration & dosage | Melphalan - pharmacology | bcl-X Protein - biosynthesis | Boronic Acids - administration & dosage | Indoles | Multiple Myeloma - enzymology | Hydroxamic Acids - pharmacology | Bortezomib | Dexamethasone - administration & dosage | Histone Deacetylases - metabolism | Drug Synergism | Acetylation - drug effects | Melphalan - administration & dosage | Multiple Myeloma - pathology | Cell Line, Tumor | Histone Deacetylase Inhibitors | Cell Cycle - drug effects | Pyrazines - pharmacology | Boronic Acids - pharmacology
MOLECULAR SEQUELAE | PROTEIN | PROMYELOCYTIC LEUKEMIA | ONCOLOGY | SUBEROYLANILIDE HYDROXAMIC ACID | INDUCED APOPTOSIS | DOWN-REGULATION | SURFACE | DEATH | MECHANISMS | MULTIPLE-MYELOMA CELLS | Apoptosis - drug effects | Humans | Pyrazines - administration & dosage | Drug Resistance, Neoplasm | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Multiple Myeloma - drug therapy | Dexamethasone - pharmacology | Hydroxamic Acids - administration & dosage | Melphalan - pharmacology | bcl-X Protein - biosynthesis | Boronic Acids - administration & dosage | Indoles | Multiple Myeloma - enzymology | Hydroxamic Acids - pharmacology | Bortezomib | Dexamethasone - administration & dosage | Histone Deacetylases - metabolism | Drug Synergism | Acetylation - drug effects | Melphalan - administration & dosage | Multiple Myeloma - pathology | Cell Line, Tumor | Histone Deacetylase Inhibitors | Cell Cycle - drug effects | Pyrazines - pharmacology | Boronic Acids - pharmacology
Journal Article
Stem Cell Reports, ISSN 2213-6711, 10/2016, Volume 7, Issue 4, pp. 602 - 618
Induced pluripotent stem cells (iPSCs) are a powerful tool for disease modeling. They are routinely generated from healthy donors and patients from multiple...
cancer reprogramming | B-ALL | DNA methylome | Sendai virus | transcriptome | iPSC | MLL-AF4 | CANCER-CELLS | MAINTENANCE | ACTIVATION | X-CHROMOSOME | ABNORMALITIES | EMBRYONIC STEM-CELLS | ADAPTATION | GENERATION | PROMOTES | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Translocation, Genetic | Humans | Precursor Cells, B-Lymphoid - metabolism | Transcriptome | Cell Transdifferentiation - genetics | Gene Expression Profiling | Cellular Reprogramming | DNA Methylation | Heterografts | Induced Pluripotent Stem Cells - cytology | Induced Pluripotent Stem Cells - metabolism | Myeloid Progenitor Cells - metabolism | Gene Expression | Hematopoietic Stem Cells - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Phenotype | Animals | Myeloid-Lymphoid Leukemia Protein - genetics | Oncogene Proteins, Fusion - genetics | Gene Rearrangement | Biomarkers | Cell Line, Tumor | Mice | Cell Line, Transformed | Cluster Analysis
cancer reprogramming | B-ALL | DNA methylome | Sendai virus | transcriptome | iPSC | MLL-AF4 | CANCER-CELLS | MAINTENANCE | ACTIVATION | X-CHROMOSOME | ABNORMALITIES | EMBRYONIC STEM-CELLS | ADAPTATION | GENERATION | PROMOTES | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Translocation, Genetic | Humans | Precursor Cells, B-Lymphoid - metabolism | Transcriptome | Cell Transdifferentiation - genetics | Gene Expression Profiling | Cellular Reprogramming | DNA Methylation | Heterografts | Induced Pluripotent Stem Cells - cytology | Induced Pluripotent Stem Cells - metabolism | Myeloid Progenitor Cells - metabolism | Gene Expression | Hematopoietic Stem Cells - metabolism | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma - genetics | Phenotype | Animals | Myeloid-Lymphoid Leukemia Protein - genetics | Oncogene Proteins, Fusion - genetics | Gene Rearrangement | Biomarkers | Cell Line, Tumor | Mice | Cell Line, Transformed | Cluster Analysis
Journal Article
Stem Cell Reports, ISSN 2213-6711, 12/2014, Volume 3, Issue 6, pp. 1118 - 1131
Neurons obtained directly from human somatic cells hold great promise for disease modeling and drug screening. Available protocols rely on overexpression of...
PLURIPOTENT STEM-CELLS | MOUSE FIBROBLASTS | PROGENITOR CELLS | DEFINED FACTORS | INDUCED NEURONAL CELLS | FUNCTIONAL-NEURONS | CORD BLOOD | IN-VIVO | ADULT HUMAN FIBROBLASTS | DOPAMINERGIC-NEURONS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cellular Senescence - genetics | Leukocytes, Mononuclear - metabolism | Gene Expression | Cell Proliferation | Humans | Cells, Cultured | Glycoproteins - metabolism | Immunophenotyping | Neurons - cytology | Gene Expression Profiling | Fetal Blood - cytology | AC133 Antigen | Antigens, CD - metabolism | Phenotype | Peptides - metabolism | Membrane Potentials | Cell Transdifferentiation | Leukocytes, Mononuclear - cytology | Neurons - metabolism | Leucòcits | Leucocytes | Xarxes neuronals (Neurobiologia) | Cell physiology | Fisiologia cel·lular | Neural networks (Neurobiology)
PLURIPOTENT STEM-CELLS | MOUSE FIBROBLASTS | PROGENITOR CELLS | DEFINED FACTORS | INDUCED NEURONAL CELLS | FUNCTIONAL-NEURONS | CORD BLOOD | IN-VIVO | ADULT HUMAN FIBROBLASTS | DOPAMINERGIC-NEURONS | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Cellular Senescence - genetics | Leukocytes, Mononuclear - metabolism | Gene Expression | Cell Proliferation | Humans | Cells, Cultured | Glycoproteins - metabolism | Immunophenotyping | Neurons - cytology | Gene Expression Profiling | Fetal Blood - cytology | AC133 Antigen | Antigens, CD - metabolism | Phenotype | Peptides - metabolism | Membrane Potentials | Cell Transdifferentiation | Leukocytes, Mononuclear - cytology | Neurons - metabolism | Leucòcits | Leucocytes | Xarxes neuronals (Neurobiologia) | Cell physiology | Fisiologia cel·lular | Neural networks (Neurobiology)
Journal Article
Cell Stem Cell, ISSN 1934-5909, 08/2012, Volume 11, Issue 2, pp. 179 - 194
Many signals must be integrated to maintain self-renewal and pluripotency in embryonic stem cells (ESCs) and to enable induced pluripotent stem cell (iPSC)...
PHOSPHORYLATION | PATHWAY | GENES | SELF-RENEWAL | A KINASE | PATIENT | INDUCTION | STEM-CELL DIFFERENTIATION | NANOG EXPRESSION | P53 | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Xenopus | Cell Line | Embryonic Stem Cells - metabolism | Phosphorylation | Cell Proliferation | Embryonic Stem Cells - cytology | Pluripotent Stem Cells - cytology | Signal Transduction | Humans | Tumor Suppressor Protein p53 - metabolism | Aurora Kinases | Tumor Suppressor Protein p53 - deficiency | Tumor Suppressor Protein p53 - genetics | Mice, Knockout | Aurora Kinase A | Pluripotent Stem Cells - metabolism | Animals | HEK293 Cells | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Differentiation | Mice | Protein-Serine-Threonine Kinases - metabolism | Cell and Molecular Biology | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cell- och molekylärbiologi | Medicinska och farmaceutiska grundvetenskaper
PHOSPHORYLATION | PATHWAY | GENES | SELF-RENEWAL | A KINASE | PATIENT | INDUCTION | STEM-CELL DIFFERENTIATION | NANOG EXPRESSION | P53 | CELL & TISSUE ENGINEERING | CELL BIOLOGY | Xenopus | Cell Line | Embryonic Stem Cells - metabolism | Phosphorylation | Cell Proliferation | Embryonic Stem Cells - cytology | Pluripotent Stem Cells - cytology | Signal Transduction | Humans | Tumor Suppressor Protein p53 - metabolism | Aurora Kinases | Tumor Suppressor Protein p53 - deficiency | Tumor Suppressor Protein p53 - genetics | Mice, Knockout | Aurora Kinase A | Pluripotent Stem Cells - metabolism | Animals | HEK293 Cells | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Differentiation | Mice | Protein-Serine-Threonine Kinases - metabolism | Cell and Molecular Biology | Basic Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Cell- och molekylärbiologi | Medicinska och farmaceutiska grundvetenskaper
Journal Article
Blood, ISSN 0006-4971, 05/2006, Volume 107, Issue 9, pp. 3575 - 3583
We explored the ability of the proteasome inhibitor bortezomib, which prevents nuclear factor kappa B (NF-kappa B) activation, to block T-cell activation,...
TRANSCRIPTION FACTORS | MULTIPLE-MYELOMA | ALLOGENEIC TRANSPLANTATION | CELLS | APOPTOSIS | ACTIVATION | LEUKEMIA | INHIBITOR | HEMATOLOGY | NF-KAPPA-B | VERSUS-HOST-DISEASE | Isoantigens | Cell Survival - drug effects | Th1 Cells - drug effects | Bortezomib | Apoptosis - drug effects | Humans | Th1 Cells - immunology | Lymphocyte Culture Test, Mixed | Protease Inhibitors - pharmacology | Graft vs Host Disease - drug therapy | T-Lymphocytes - cytology | Lymphocyte Activation - drug effects | T-Lymphocytes - drug effects | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Th1 Cells - cytology | In Vitro Techniques | Pyrazines - pharmacology | Cytokines - biosynthesis | Boronic Acids - pharmacology
TRANSCRIPTION FACTORS | MULTIPLE-MYELOMA | ALLOGENEIC TRANSPLANTATION | CELLS | APOPTOSIS | ACTIVATION | LEUKEMIA | INHIBITOR | HEMATOLOGY | NF-KAPPA-B | VERSUS-HOST-DISEASE | Isoantigens | Cell Survival - drug effects | Th1 Cells - drug effects | Bortezomib | Apoptosis - drug effects | Humans | Th1 Cells - immunology | Lymphocyte Culture Test, Mixed | Protease Inhibitors - pharmacology | Graft vs Host Disease - drug therapy | T-Lymphocytes - cytology | Lymphocyte Activation - drug effects | T-Lymphocytes - drug effects | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Th1 Cells - cytology | In Vitro Techniques | Pyrazines - pharmacology | Cytokines - biosynthesis | Boronic Acids - pharmacology
Journal Article
British Journal of Haematology, ISSN 0007-1048, 12/2003, Volume 123, Issue 5, pp. 858 - 868
c‐Kit has been shown to be mutated in several types of tumours, and its activity has been correlated with increased proliferation rates in a subset of multiple...
imatinib mesylate | multiple myeloma | tyrosine kinase inhibitor | Tyrosine kinase inhibitor | Imatinib mesylate | Multiple myeloma | TYROSINE KINASE | GROWTH | TUMOR | PTEN | C-KIT | LEUKEMIA | LIGAND | HEMATOLOGY | EXPRESSION | Humans | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Multiple Myeloma - metabolism | Imatinib Mesylate | Cell Division - drug effects | Drug Synergism | Dexamethasone - therapeutic use | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | Flow Cytometry | Pyrimidines - therapeutic use | Cell Line, Tumor | Benzamides | Enzyme Activation | Cell Cycle - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors
imatinib mesylate | multiple myeloma | tyrosine kinase inhibitor | Tyrosine kinase inhibitor | Imatinib mesylate | Multiple myeloma | TYROSINE KINASE | GROWTH | TUMOR | PTEN | C-KIT | LEUKEMIA | LIGAND | HEMATOLOGY | EXPRESSION | Humans | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Multiple Myeloma - metabolism | Imatinib Mesylate | Cell Division - drug effects | Drug Synergism | Dexamethasone - therapeutic use | Multiple Myeloma - drug therapy | Multiple Myeloma - pathology | Flow Cytometry | Pyrimidines - therapeutic use | Cell Line, Tumor | Benzamides | Enzyme Activation | Cell Cycle - drug effects | Mitogen-Activated Protein Kinases - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors
Journal Article
Current Opinion in Cardiology, ISSN 0268-4705, 05/2011, Volume 26, Issue 3, pp. 223 - 229
PURPOSE OF REVIEWThe development of induced pluripotent stem cell (iPSC) technology has led to many advances in the areas of directed cell differentiation and...
hypertrophic cardiomyopathy | induced pluripotent stem cells | LEOPARD syndrome | long-QT syndrome | LEOPARD-SYNDROME | PROGENITORS | DEFINED FACTORS | CARDIAC & CARDIOVASCULAR SYSTEMS | PTPN11 | NOONAN-SYNDROME | FIBROBLASTS | BODIES | DIFFERENTIATION | MUTATIONS | Myocytes, Cardiac | Humans | Fibroblasts | Long QT Syndrome - genetics | Cell Differentiation | Models, Genetic | Cardiovascular Diseases - genetics | Induced Pluripotent Stem Cells
hypertrophic cardiomyopathy | induced pluripotent stem cells | LEOPARD syndrome | long-QT syndrome | LEOPARD-SYNDROME | PROGENITORS | DEFINED FACTORS | CARDIAC & CARDIOVASCULAR SYSTEMS | PTPN11 | NOONAN-SYNDROME | FIBROBLASTS | BODIES | DIFFERENTIATION | MUTATIONS | Myocytes, Cardiac | Humans | Fibroblasts | Long QT Syndrome - genetics | Cell Differentiation | Models, Genetic | Cardiovascular Diseases - genetics | Induced Pluripotent Stem Cells
Journal Article
The Journal of Pathology, ISSN 0022-3417, 01/2006, Volume 208, Issue 1, pp. 108 - 118
Malignant plasma cells in multiple myeloma home to the bone marrow (BM), accumulate in different niches and, in late disease, migrate from the BM into blood....
migration | multiple myeloma | chemokines, metalloproteinases | invasion | Metalloproteinases | Migration | Chemokines | Invasion | Multiple myeloma | 1-MATRIX METALLOPROTEINASE | metalloproteinases | PATHOLOGY | chemokines | CANCER | MATRIX METALLOPROTEINASES | ADHESION | MARROW ENDOTHELIAL-CELLS | UP-REGULATION | EXPRESSION | HUMAN MULTIPLE-MYELOMA | Stromal Cells - pathology | Humans | Gene Expression Regulation, Neoplastic | Extracellular Matrix - metabolism | Neoplasm Proteins - metabolism | Basement Membrane - pathology | Cell Movement - physiology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Matrix Metalloproteinase 9 - metabolism | Laminin | Matrix Metalloproteinases, Membrane-Associated | Chemokine CXCL12 | Collagen Type I - metabolism | Proteoglycans | Neoplasm Invasiveness | Stromal Cells - metabolism | Matrix Metalloproteinases - analysis | Multiple Myeloma - metabolism | Basement Membrane - metabolism | Multiple Myeloma - pathology | Collagen | Chemokines, CXC - metabolism | Cell Line, Tumor | Biocompatible Materials | Matrix Metalloproteinases - metabolism | Drug Combinations
migration | multiple myeloma | chemokines, metalloproteinases | invasion | Metalloproteinases | Migration | Chemokines | Invasion | Multiple myeloma | 1-MATRIX METALLOPROTEINASE | metalloproteinases | PATHOLOGY | chemokines | CANCER | MATRIX METALLOPROTEINASES | ADHESION | MARROW ENDOTHELIAL-CELLS | UP-REGULATION | EXPRESSION | HUMAN MULTIPLE-MYELOMA | Stromal Cells - pathology | Humans | Gene Expression Regulation, Neoplastic | Extracellular Matrix - metabolism | Neoplasm Proteins - metabolism | Basement Membrane - pathology | Cell Movement - physiology | Tissue Inhibitor of Metalloproteinase-1 - metabolism | Matrix Metalloproteinase 9 - metabolism | Laminin | Matrix Metalloproteinases, Membrane-Associated | Chemokine CXCL12 | Collagen Type I - metabolism | Proteoglycans | Neoplasm Invasiveness | Stromal Cells - metabolism | Matrix Metalloproteinases - analysis | Multiple Myeloma - metabolism | Basement Membrane - metabolism | Multiple Myeloma - pathology | Collagen | Chemokines, CXC - metabolism | Cell Line, Tumor | Biocompatible Materials | Matrix Metalloproteinases - metabolism | Drug Combinations
Journal Article
Blood, ISSN 0006-4971, 06/2005, Volume 105, Issue 11, pp. 4492 - 4499
Multiple myeloma is characterized by the accumulation of terminally differentiated B cells in the bone marrow, due to increased proliferation and restricted...
SIGNAL-TRANSDUCTION | MAMMALIAN MAP KINASE | ACTIVATED PROTEIN-KINASE | INDUCED APOPTOSIS | ENDOTHELIAL-CELLS | GENE-EXPRESSION | CELL-PROLIFERATION | TYROSINE KINASES | GROWTH-FACTOR | HEMATOLOGY | 1 BMK1 | Bortezomib | Cell Proliferation | Signal Transduction | Humans | Enzyme Activation - drug effects | Multiple Myeloma - etiology | Multiple Myeloma - pathology | Dexamethasone - pharmacology | Interleukin-6 - pharmacology | Mitogen-Activated Protein Kinase 7 - analysis | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Multiple Myeloma - enzymology | Pyrazines - pharmacology | Mitogen-Activated Protein Kinase 7 - physiology | Apoptosis | Boronic Acids - pharmacology
SIGNAL-TRANSDUCTION | MAMMALIAN MAP KINASE | ACTIVATED PROTEIN-KINASE | INDUCED APOPTOSIS | ENDOTHELIAL-CELLS | GENE-EXPRESSION | CELL-PROLIFERATION | TYROSINE KINASES | GROWTH-FACTOR | HEMATOLOGY | 1 BMK1 | Bortezomib | Cell Proliferation | Signal Transduction | Humans | Enzyme Activation - drug effects | Multiple Myeloma - etiology | Multiple Myeloma - pathology | Dexamethasone - pharmacology | Interleukin-6 - pharmacology | Mitogen-Activated Protein Kinase 7 - analysis | Antineoplastic Agents - pharmacology | Tumor Cells, Cultured | Multiple Myeloma - enzymology | Pyrazines - pharmacology | Mitogen-Activated Protein Kinase 7 - physiology | Apoptosis | Boronic Acids - pharmacology
Journal Article